MCQ Quiz: Pulmonary- Acute Respiratory Distress Syndrome (ARDS)

Acute Respiratory Distress Syndrome (ARDS) is a life-threatening form of respiratory failure characterized by widespread inflammation in the lungs. Managing ARDS requires a deep, integrated understanding of respiratory pathophysiology, mechanical ventilation, and critical care pharmacotherapy. For PharmD students, this topic tests the ability to apply foundational knowledge to a complex, high-acuity clinical scenario. This quiz will cover the causes, presentation, and management principles of ARDS, reflecting the pharmacist’s vital role on the ICU team.


1. A patient presenting with rapid, shallow breathing, use of accessory muscles, and cyanosis is exhibiting classic signs of:

  • A hypertensive crisis.
  • Respiratory distress.
  • A stroke.
  • Hypoglycemia.

Answer: Respiratory distress.


2. Acute Respiratory Distress Syndrome (ARDS) is characterized by which of the following pathophysiological processes?

  • Bronchoconstriction and airway hyperresponsiveness.
  • Progressive narrowing of the pulmonary arteries.
  • Widespread inflammation of the lungs leading to fluid leakage into the alveoli.
  • A bacterial infection of the pleural space.

Answer: Widespread inflammation of the lungs leading to fluid leakage into the alveoli.


3. From a pulmonary function perspective, ARDS is considered what type of lung disease?

  • Obstructive
  • Central
  • Vascular
  • Restrictive

Answer: Restrictive


4. Which of the following is a common cause of ARDS?

  • Mild asthma
  • Sepsis or severe pneumonia
  • Chronic hypertension
  • Atrial fibrillation

Answer: Sepsis or severe pneumonia


5. The cornerstone of management for a patient with moderate to severe ARDS is:

  • Oral antibiotic therapy.
  • High-dose corticosteroid administration.
  • Mechanical ventilation with supportive care.
  • Frequent nebulizer treatments.

Answer: Mechanical ventilation with supportive care.


6. Ventilator-Associated Pneumonia (VAP) is a serious complication for patients with ARDS. It is defined as pneumonia that occurs:

  • Before the patient is intubated.
  • In a patient who is not on a ventilator.
  • More than 48 hours after endotracheal intubation.
  • Within 24 hours of hospital admission.

Answer: More than 48 hours after endotracheal intubation.


7. A key strategy to prevent Ventilator-Associated Pneumonia (VAP) is:

  • Keeping the patient in a supine (flat) position.
  • Avoiding all sedation.
  • Elevating the head of the bed to 30-45 degrees.
  • Administering prophylactic broad-spectrum antibiotics for the duration of ventilation.

Answer: Elevating the head of the bed to 30-45 degrees.


8. Patients on mechanical ventilation for ARDS often require sedation and analgesia to:

  • Promote ventilator synchrony and patient comfort.
  • Increase their respiratory drive.
  • Prevent blood clots.
  • Treat the underlying cause of the ARDS.

Answer: Promote ventilator synchrony and patient comfort.


9. The primary goal of fluid management in a patient with ARDS (after initial resuscitation) is typically to:

  • Administer large volumes of IV fluids to maintain a high central venous pressure.
  • Pursue a conservative or “dry” fluid strategy to reduce pulmonary edema.
  • Use only colloid fluids like albumin.
  • Avoid all intravenous fluids.

Answer: Pursue a conservative or “dry” fluid strategy to reduce pulmonary edema.


10. What is the pharmacist’s role in managing a sedated, mechanically ventilated patient?

  • Recommending and dosing appropriate sedatives and analgesics.
  • Managing “sedation holidays” to assess neurologic function.
  • Monitoring for drug accumulation due to organ dysfunction.
  • All of the above.

Answer: All of the above.


11. The pathophysiology of ARDS involves damage to the alveolar-capillary membrane, which leads to:

  • Increased lung compliance.
  • Improved gas exchange.
  • An influx of protein-rich fluid into the alveoli, causing non-cardiogenic pulmonary edema.
  • A decrease in pulmonary inflammation.

Answer: An influx of protein-rich fluid into the alveoli, causing non-cardiogenic pulmonary edema.


12. The diagnosis of ARDS requires:

  • A normal chest x-ray.
  • The presence of cardiogenic pulmonary edema or heart failure.
  • Acute onset of hypoxemia and bilateral opacities on chest imaging, not fully explained by cardiac failure.
  • A positive blood culture.

Answer: Acute onset of hypoxemia and bilateral opacities on chest imaging, not fully explained by cardiac failure.


13. In the initial first response to a patient in severe respiratory distress, the priority is:

  • Determining their insurance status.
  • Performing a detailed medication history.
  • Ensuring a patent airway and providing oxygenation/ventilation support (ABCs).
  • Obtaining a chest x-ray.

Answer: Ensuring a patent airway and providing oxygenation/ventilation support (ABCs).


14. A neuromuscular blocking agent (NMBA) may be used in a patient with severe ARDS to:

  • Treat the underlying infection.
  • Prevent paralysis of the diaphragm.
  • Improve patient-ventilator synchrony and prevent ventilator-induced lung injury.
  • Provide sedation and analgesia.

Answer: Improve patient-ventilator synchrony and prevent ventilator-induced lung injury.


15. A major role for the critical care pharmacist on ICU rounds for an ARDS patient is:

  • Verifying medication orders for accuracy.
  • Providing recommendations on drug selection and dosing.
  • Monitoring for adverse drug events and drug interactions.
  • All of the above.

Answer: All of the above.


16. Which of the following is a key component of supportive care for any critically ill patient, including those with ARDS?

  • Prophylaxis for venous thromboembolism (VTE).
  • Prophylaxis for stress-related mucosal bleeding.
  • Nutritional support.
  • All of the above.

Answer: All of the above.


17. The primary goal of mechanical ventilation in ARDS is to:

  • Cure the underlying cause of the lung injury.
  • Provide adequate oxygenation while minimizing further ventilator-induced lung injury (VILI).
  • Keep the patient comfortable until they recover on their own.
  • Allow the patient to be fully awake and interactive.

Answer: Provide adequate oxygenation while minimizing further ventilator-induced lung injury (VILI).


18. What does “hypoxemia” mean?

  • Low levels of carbon dioxide in the blood.
  • Low levels of oxygen in the blood.
  • High levels of oxygen in the blood.
  • High levels of carbon dioxide in the blood.

Answer: Low levels of oxygen in the blood.


19. Prone positioning (placing the patient on their stomach) is a non-pharmacologic intervention used in some patients with severe ARDS to:

  • Make the patient more comfortable.
  • Improve oxygenation by recruiting posterior lung segments.
  • Prevent pressure ulcers.
  • Decrease the risk of VAP.

Answer: Improve oxygenation by recruiting posterior lung segments.


20. A pharmacist might recommend against using a benzodiazepine for continuous sedation in an ARDS patient due to:

  • Its high cost compared to other agents.
  • Its association with an increased risk of delirium in the ICU.
  • Its lack of sedative effect.
  • Its beneficial effects on lung compliance.

Answer: Its association with an increased risk of delirium in the ICU.


21. In the pathophysiology of restrictive lung disease like ARDS, what happens to lung compliance?

  • It increases, making the lungs easier to inflate.
  • It remains unchanged.
  • It decreases, making the lungs stiff and difficult to inflate.
  • It becomes highly variable.

Answer: It decreases, making the lungs stiff and difficult to inflate.


22. Which of the following is a common vasopressor used to support blood pressure in a patient with ARDS secondary to septic shock?

  • Furosemide
  • Norepinephrine
  • Esmolol
  • Lorazepam

Answer: Norepinephrine


23. The “response” phase of a disaster, such as a pandemic causing a surge of ARDS patients, involves:

  • Actions taken long after the event to return to normal.
  • Immediate actions to save lives and meet urgent needs.
  • Efforts to prevent the disaster from happening.
  • Writing a disaster preparedness manual.

Answer: Immediate actions to save lives and meet urgent needs.


24. The pharmacist’s knowledge of sterile compounding is critical in the ARDS setting for preparing:

  • Oral medications.
  • Intravenous infusions of sedatives, vasopressors, and other critical care drugs.
  • Topical creams.
  • Inhaled medications.

Answer: Intravenous infusions of sedatives, vasopressors, and other critical care drugs.


25. A major challenge in managing ARDS is that:

  • It is a single disease with a simple, curative treatment.
  • The mortality rate is very low.
  • Treatment is primarily supportive, aimed at the underlying cause while allowing the lungs to heal.
  • Patients are typically not in the ICU.

Answer: Treatment is primarily supportive, aimed at the underlying cause while allowing the lungs to heal.


26. A patient is intubated for ARDS. This means:

  • They are receiving oxygen through a nasal cannula.
  • A breathing tube has been inserted into their trachea and connected to a mechanical ventilator.
  • They are using a non-invasive BiPAP machine.
  • They have had a surgical tracheostomy.

Answer: A breathing tube has been inserted into their trachea and connected to a mechanical ventilator.


27. The pharmacist’s role in VAP prevention includes:

  • Ensuring appropriate drug selection for stress ulcer prophylaxis (e.g., avoiding routine PPI use where not indicated).
  • Recommending appropriate sedation strategies to facilitate early weaning.
  • Verifying appropriate antibiotic selection if VAP develops.
  • All of the above.

Answer: All of the above.


28. Why is nutritional support crucial for a patient with ARDS?

  • To prevent weight gain.
  • Because critical illness induces a hypermetabolic and hypercatabolic state, leading to malnutrition.
  • To ensure the patient enjoys their hospital stay.
  • It is not a major consideration.

Answer: Because critical illness induces a hypermetabolic and hypercatabolic state, leading to malnutrition.


29. The term “pulmonary edema” refers to:

  • A collapsed lung.
  • Excess fluid in the lungs.
  • An infection of the lung tissue.
  • A blood clot in the lungs.

Answer: Excess fluid in the lungs.


30. In ARDS, the pulmonary edema is “non-cardiogenic,” meaning it is NOT caused by:

  • Increased permeability of the lung capillaries.
  • An inflammatory process.
  • Heart failure.
  • Sepsis.

Answer: Heart failure.


31. The use of a “sedation holiday” or daily interruption of sedation in a ventilated patient is a practice designed to:

  • Increase the total amount of sedative used.
  • Assess the patient’s neurologic status and readiness for weaning from the ventilator.
  • Cause discomfort to the patient.
  • Make the nurse’s job more difficult.

Answer: Assess the patient’s neurologic status and readiness for weaning from the ventilator.


32. The primary sign of respiratory distress a first responder might observe is:

  • A normal respiratory rate.
  • An abnormally fast respiratory rate (tachypnea).
  • A slow respiratory rate (bradypnea).
  • No breathing at all (apnea).

Answer: An abnormally fast respiratory rate (tachypnea).


33. Which of the following best describes the pharmacist’s role in a medical emergency like ARDS?

  • A medication expert who is an integral part of the interprofessional care team.
  • A technician responsible only for delivering medications.
  • An observer with no active role.
  • A manager of the hospital’s budget.

Answer: A medication expert who is an integral part of the interprofessional care team.


34. A patient with ARDS develops a new fever and an elevated white blood cell count. This is most concerning for:

  • Recovery from ARDS.
  • A secondary infection, such as VAP.
  • An adverse drug reaction.
  • A normal response to mechanical ventilation.

Answer: A secondary infection, such as VAP.


35. A pharmacist adjusting a drug dose in an ARDS patient with concurrent acute kidney injury is an application of:

  • Pharmacokinetic principles in a critically ill patient.
  • Medicinal chemistry.
  • Pharmacy law.
  • Health economics.

Answer: Pharmacokinetic principles in a critically ill patient.


36. The “Response” phase of a disaster is characterized by:

  • Long-term rebuilding efforts.
  • Actions to lessen the impact of a future disaster.
  • The immediate period of saving lives and providing critical care.
  • Writing the preparedness manual.

Answer: The immediate period of saving lives and providing critical care.


37. When a neuromuscular blocker is used, what other type of medication is absolutely essential to provide concurrently?

  • An antibiotic
  • A diuretic
  • A sedative and an analgesic.
  • A vasopressor

Answer: A sedative and an analgesic.


38. The use of low tidal volume ventilation is a strategy in ARDS management designed to:

  • Increase the risk of barotrauma.
  • Provide more oxygen to the patient.
  • Prevent ventilator-induced lung injury by avoiding over-distention of the alveoli.
  • Make the patient more comfortable.

Answer: Prevent ventilator-induced lung injury by avoiding over-distention of the alveoli.


39. The pathophysiology of ARDS can be simplified as a loss of the barrier between the:

  • Bronchioles and the alveoli.
  • Capillaries and the alveoli.
  • Trachea and the esophagus.
  • Pleural space and the lung parenchyma.

Answer: Capillaries and the alveoli.


40. A common laboratory finding in a patient with ARDS is:

  • A high PaO2/FiO2 ratio.
  • A low PaO2/FiO2 ratio, indicating poor oxygenation.
  • Normal arterial blood gas values.
  • An elevated hemoglobin level.

Answer: A low PaO2/FiO2 ratio, indicating poor oxygenation.


41. The recovery from ARDS:

  • Is always rapid and complete.
  • Can be a long process, often with residual physical and cognitive impairments.
  • Does not require physical therapy.
  • Ends immediately upon discharge from the ICU.

Answer: Can be a long process, often with residual physical and cognitive impairments.


42. Which of the following is an example of an “obstructive” lung disease, as opposed to a restrictive one like ARDS?

  • Pulmonary fibrosis
  • Sarcoidosis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Scoliosis

Answer: Chronic Obstructive Pulmonary Disease (COPD)


43. A pharmacist on the first response team would need to be knowledgeable about:

  • Basic life support (BLS).
  • Triage principles.
  • The initial management of respiratory distress.
  • All of the above.

Answer: All of the above.


44. The stress and burnout experienced by healthcare professionals working in an ICU with ARDS patients is a form of:

  • Physical trauma.
  • Psychological and emotional trauma.
  • A positive career development experience.
  • An expected part of the job with no negative consequences.

Answer: Psychological and emotional trauma.


45. Which of the following is a key role of the pharmacist in managing a patient on a vasopressor?

  • Titrating the infusion based on blood pressure response.
  • Ensuring the correct concentration and infusion rate.
  • Monitoring for extravasation.
  • All of the above are roles a pharmacist may have, depending on institutional policy.

Answer: All of the above are roles a pharmacist may have, depending on institutional policy.


46. The main purpose of providing stress ulcer prophylaxis in a mechanically ventilated patient is to:

  • Treat an active GI bleed.
  • Prevent a clinically significant bleed from stress-related mucosal damage.
  • Neutralize all stomach acid.
  • Improve the absorption of other medications.

Answer: Prevent a clinically significant bleed from stress-related mucosal damage.


47. A “daily awakening trial” is another term for a:

  • Sedation holiday.
  • Trial of spontaneous breathing.
  • Prone positioning trial.
  • Diuretic challenge.

Answer: Sedation holiday.


48. The diagnosis of hospital-acquired pneumonia (HAP) requires that the pneumonia was not incubating at the time of hospital admission and develops:

  • Within the first 24 hours of admission.
  • More than 48 hours after hospital admission.
  • Only in patients in the emergency department.
  • After the patient has been discharged.

Answer: More than 48 hours after hospital admission.


49. The overall goal of supportive care in ARDS is to:

  • Cure the lung injury with a single medication.
  • Support organ function while the lungs heal from the initial insult.
  • Focus only on the patient’s respiratory status.
  • Discharge the patient from the ICU as quickly as possible.

Answer: Support organ function while the lungs heal from the initial insult.


50. An interprofessional team approach is critical in managing ARDS because:

  • The complexity of the illness requires the coordinated expertise of physicians, nurses, respiratory therapists, and pharmacists.
  • It is a requirement for hospital accreditation only.
  • It makes decision-making slower and less efficient.
  • Each profession can work in isolation to achieve the best outcomes.

Answer: The complexity of the illness requires the coordinated expertise of physicians, nurses, respiratory therapists, and pharmacists.

Author

  • G S Sachin Author Pharmacy Freak
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators